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BIG DATA ANALYTICS:  WHAT CAN GO WRONG
SHARONA HOFFMAN*
Abstract:  It is not uncommon to read that long-held beliefs about medical
treatments have been dislodged by new studies. For example, there is now doubt
as to whether women should undergo annual mammograms, previously a
cornerstone of cancer screening. Hormone replacement therapy for menopausal
women, once considered highly suspect in light of worrisome research findings,
is now being reconsidered as a beneficial therapy. These reversals trouble and
confuse many Americans.
This Article explores why medical research findings can be erroneous and
what can go wrong in the process of designing and conducting research studies.
It provides readers with essential analytical tools and scientific vocabulary. The
challenges of medical research include data quality deficiencies; selection,
confounding, measurement, and confirmation biases; inadequate sample sizes;
sampling errors; effect modifiers; and causal interactions, among others. All of
these can cause researchers to mistake mere associations for causal relationships
and to reach conclusions that are invalid and cannot be replicated in subsequent
studies.  
Erroneous research findings can mislead legislators, regulators, and lawyers
who use them for purposes of policy-making or litigation. Thus, understanding
the pitfalls of big data analysis is important not only for scientists but also for
anyone working with or reading about research studies, that is, for attorneys,
health policy professionals, and the public at large.
I. INTRODUCTION
Big data analysis can be a valuable addition to the research toolkit and fill
many knowledge gaps.  It is unclear, however, whether the proliferation of1
research endeavors will consistently advance scientific truths.
Big data research is relevant to health law and policy because it can be used
in litigation by both plaintiffs and defendants.  Based on studies that reveal2
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Medicine Center, Case Western Reserve University School of Law; B.A., Wellesley College; J.D.,
Harvard Law School; LL.M. in Health Law, University of Houston; S.J.D. in Health Law, Case
Western Reserve University. This article is based in part on Sharona Hoffman & Andy Podgurski,
The Use and Misuse of Biomedical Data:  Is Bigger Really Better?, 39 AM. J. L. & MED. 497
(2013) and SHARONA HOFFMAN, Medical Big Data Quality and Analysis Concerns, in ELECTRONIC
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1. Sharona Hoffman & Andy Podgurski, The Use and Misuse of Biomedical Data: Is Bigger
Really Better?, 39 AM. J. L. & MED. 497, 499 (2013).
2. DAVID L. FAIGMAN ET AL., MODERN SCIENTIFIC EVIDENCE:  STANDARDS, STATISTICS,
AND RESEARCH METHODS 338-42 (student ed., 2008); Bernard Marr, How Big Data Is Disrupting
Law Firms and the Legal Profession, FORBES (Jan. 20, 2016), https://www.forbes.com/
sites/bernardmarr/2016/01/20/how-big-data-is-disrupting-law-firms-and-the-legal-
profession/#328c59227c23 [https://perma.cc/4MXA-N45S] (stating that lawyers “are starting to
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statistical associations between illnesses and exposure to certain substances,
plaintiffs may file tort cases against product manufacturers. For their part,
defendants may use different studies to undermine plaintiffs’ claims and argue
that something other than their products caused the conditions in question.3
In addition, responsible legislators and policy-makers often rely on research
findings for purposes of formulating laws, regulations, and policies. When the
studies they review are wrong, government authorities can impose needless
burdens on the public or, worse yet, cause harm.   4
Two notorious examples illustrate the potential influence of erroneous
research outcomes. A 1998 study published in the prestigious journal, Lancet,
suggested that the measles, mumps, rubella (MMR) vaccination caused autism.5
While the study was later retracted,  the belief that vaccinations can lead to6
autism gained traction  and still needs to be explicitly rebutted on the Centers for7
Disease Control and Prevention’s website.  It is not inconceivable that such a8
study could have convinced state legislatures to relax vaccination requirements
before it was disavowed.
In 2009, the Journal of Psychiatric Research published a study that claimed
to have discovered a causal link between abortion and psychiatric disorders.  The9
researchers reviewed “national data sets with reproductive history and mental
health variables” to formulate their findings.  Abortion foes widely cited the10
study,  and several states in fact enacted laws requiring women who want11
think about how this technology could be applied to the fundamental research and case preparation
which is the core of their job.”). 
3. FAIGMAN ET AL., supra note 2, at 339-40 (explaining that epidemiological evidence has
already played an important role in many mass tort cases); Steve C. Gold, The More We Know, the
Less Intelligent We Are? – How Genomic Information Should, and Should Not, Change Toxic Tort
Causation Doctrine, 34 HARV. ENVTL. L. REV. 369, 412-17 (2010) (discussing genes and other
toxins as alternate causes of plaintiffs’ injuries).
4. Hoffman & Podgurski, supra note 1, at 500-01.
5. Andrew J. Wakefield et al., Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis,
and Pervasive Developmental Disorder in Children, 351 LANCET 637, 641 (1998).
6. Simon H. Murch et al., Retraction of an Interpretation, 363 LANCET 750, 750 (2004). 
7. Jack Healy & Michael Paulson, Vaccine Critics Turn Defensive over Measles, N.Y.
TIMES (Jan. 30, 2015), https://www.nytimes.com/2015/01/31/us/vaccine-critics-turn-defensive-
over-measles.html?mcubz=0 [https://perma.cc/ZJ32-DWC7].
8. Measles, Mumps, and Rubella (MMR) Vaccine Safety Studies, CDC, http://www .cdc
.gov/ vaccinesafety/ Vaccines/ MMR/ MMR.html [https://perma.cc/FT5D-HJ54] (last updated Aug.
28, 2015).
9. Priscilla K. Coleman et al., Induced Abortion and Anxiety, Mood, and Substance Abuse
Disorders: Isolating the Effects of Abortion in the National Comorbidity Survey, 43 J. PSYCHOL.
RES. 770, 773 (2009).
10. Id. 
11. Sharon Begley, Journal Disavows Study Touted by U.S. Abortion Foes, REUTERS (Mar.
7, 2012, 3:15 PM), http://www.reuters.com/article/2012/03/07/us-usa-abortion-psychiatry-
idUSTRE8261UD20120307 [https://perma.cc/T2WQ-U2C8] (stating that the study had been
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abortions to receive counseling that warns them of potential long-term mental
health problems.  The study was discredited in 2012 when scientists found that12
its design was deeply flawed.  The original researchers did not compare women13
with unplanned pregnancies who had abortions to those who did not and failed
to focus only on mental health problems that manifested after abortions.  Thus,14
legislative initiatives were based on invalid findings.
 There are many other examples of research findings that have gained
extensive media coverage, but all too frequently, they are later questioned or
contradicted.  These reversals can be perplexing and frustrating.  A 2010 article15 16
in The Atlantic bemoaned the phenomenon of conflicting, highly publicized
research outcomes:
And they sometimes make headlines, as when in recent years large
studies or growing consensuses of researchers concluded that
mammograms, colonoscopies, and PSA tests are far less useful cancer-
detection tools than we had been told; or when widely prescribed
antidepressants such as Prozac, Zoloft, and Paxil were revealed to be no
more effective than a placebo for most cases of depression; or when we
learned that staying out of the sun entirely can actually increase cancer
risks; or when we were told that the advice to drink lots of water during
intense exercise was potentially fatal; or when, last April, we were
informed that taking fish oil, exercising, and doing puzzles doesn’t really
help fend off Alzheimer’s disease, as long claimed. Peer-reviewed
studies have come to opposite conclusions on whether using cell phones
can cause brain cancer, whether sleeping more than eight hours a night
is healthful or dangerous, whether taking aspirin every day is more likely
to save your life or cut it short, and whether routine angioplasty works
better than pills to unclog heart arteries.17
This Article explores why medical research findings can be erroneous and
“widely cited by legislators and advocates to argue that abortion raises a woman's risk of mental
illness and to push for laws requiring providers” to inform women of this danger). 
12. Counseling and Waiting Periods for Abortion, GUTTMACHER INST.: STATE POLICIES IN
BRIEF (2018), http://www.guttmacher.org/statecenter/spibs/spib_MWPA.pdf [https://perma.cc/
49By-RL9A].  
13. Ronald C. Kessler & Alan F. Schatzberg, Commentary on Abortion Studies of Steinberg
and Finer (Social Science & Medicine 2011; 72:72–82) and Coleman (Journal of Psychiatric
Research 2009;43:770–6 & Journal of Psychiatric Research 2011;45:1133–4), 46 J. PSYCHOL.
RES. 410, 410-411 (2012).
14. Id. at 410.
15. David H. Freedman, Lies, Damned Lies, and Medical Science, THE ATLANTIC (Nov.
2010), https://www.theatlantic.com/magazine/archive/2010/11/lies-damned-lies-and-medical-
science/308269/ [https://perma.cc/K9LG-YGNE]. 
16. Rebekah H. Nagler, Adverse Outcomes Associated with Media Exposure to Contradictory
Nutrition Messages, 19 J. HEALTH COMM. 24, 24 (2014).
17. Freedman, supra note 15.
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what can go wrong in the process of designing and conducting research studies.
It provides readers with essential analytical tools and scientific vocabulary.
Understanding the pitfalls of big data analysis is important not only for scientists
but also for anyone working with or reading about research studies, that is, for
attorneys, health policy professionals, and the public at large.
Big data analysis can face many challenges. First, as discussed in Part II, the
data that researchers review can be fraught with errors, incomplete, fragmented,
or otherwise flawed.  Second, Part III analyzes a variety of biases that can distort18
research findings, including selection bias, confounding bias, measurement bias,
and confirmation bias.  Part IV explores additional research obstacles.  For19 20
example, sample sizes can be too small to produce reliable research results,
sampling errors may exist, treatment effects can vary between individuals because
of effect modifiers, and researchers might fail to discover causal interactions
among multiple causal factors.  As explained in Part V, all of these problems can21
cause researchers to mistake mere associations for causation and to reach
outcomes that cannot be replicated and confirmed in subsequent studies. Thus,
research errors and debunked studies are common phenomena. Finally, Part VI
concludes.
II. DATA QUALITY
Medical big data analysis often draws upon electronic health records (EHRs). 
A key hurdle to conducting record-based research is that existing EHRs often
contain errors, are incomplete, or suffer from other shortcomings. The
information in EHRs is initially collected for medical treatment and billing
purposes, so it may be ill-suited for research.  Moreover, data are often22
contaminated by a myriad of inaccuracies that can compromise research
outcomes. Though improved data-capture technology may remedy many
shortcomings in the future,  these deficiencies should be a significant concern to23
contemporary researchers.  This section discusses a number of potential data
quality problems.
A. Data Can be Entered Incorrectly
Clinicians inputting EHR data can mistype words and numbers or copy and
paste information from a prior date into a current visit’s entry in order to save
time without editing and updating it appropriately. They can also select the wrong
EHR codes and menu items or be forced to choose among diagnosis or treatment
codes that are not specific or detailed enough to describe the patient’s condition
18. See infra Part II.
19. See infra Part III.  
20. See infra Part IV.
21. See infra Part IV.
22. Hoffman & Podgurski, supra note 1, at 518-20.
23. Id. at 527-30.
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accurately.   24
Some research suggests that error rates in EHRs are considerably higher than
they were in paper records.  In one study, researchers examined progress notes25
made between August 2011 and July 2013 at a Michigan hospital that
implemented an EHR system in 2012.  They found an error rate of 24.4 percent26
in EHRs compared to a 4.4 percent error rate in paper records.  It is noteworthy,27
however, that the study was conducted when the EHR system was first adopted
and staff had to learn the new technology.  Moreover, the researchers found that28
medical residents, who are presumably more tech-savvy than the prior generation
of physicians, had far fewer errors and omissions than their older colleagues, so
that error rates might decline appreciably in the future.  It is also significant that29
EHRs have largely eliminated the serious problem of illegible handwriting in
medical records, unless their contents are transcribed from handwritten notes.30
Data inaccuracies can distort research outcomes. Even a small error rate, as
low as one to five percent, can significantly impact estimates of mortality and
adverse events.  As incidents of hacking and cybercrimes proliferate, data31
analysts also cannot ignore the possibility that hackers will access EHR medical
databases and purposefully alter and taint them.32
24. Sharona Hoffman & Andy Podgurski, E-Health Hazards: Provider Liability and
Electronic Health Record Systems, 24 BERKELEY TECH. L. J. 1523, 1544-45 (2009) (discussing
input errors); Taxiarchis Botsis et al., Secondary Use of EHR: Data Quality Issues and Informatics
Opportunities, AMIA SUMMITS TRANSLATIONAL SCI. PROC. 1, 3 (2010); Jessica S. Ancker et al.,
Root Causes Underlying Challenges to Secondary Use of Data, AMIA ANN. SYMP. PROC. ARCHIVE
57, 61 (2011); Hoffman & Podgurski, supra note 1 at 518-20 (discussing coding); Fouzia F. Ozair,
Ethical Issues in Electronic Health Records: A General Overview, 6 PERSP. CLINICAL RES. 73, 75-
76 (Apr-Jun 2015).
25. Jack McCarthy, Doctors Make More Note-Taking Mistakes with EHRs than Paper
Records, JAMIA Study Finds, HEALTHCARE IT NEWS (July 8, 2016, 7:58 AM), http://www.
healthcareitnews.com/news/doctors-make-more-note-taking-mistakes-ehrs-paper-records-jamia-
study-finds [https://perma.cc/W8WG-55KU].  
26. Id.
27. Id.
28. Id.
29. Id. (noting that the error rates were 5.3% versus 17.3%, and the omission rates were
16.8% versus 33.9%).
30. WIN PHILLIPS & YANG GONG, DEVELOPING A NOMENCLATURE FOR EMR ERRORS:
PROCEEDINGS OF THE 13TH INTERNATIONAL CONFERENCE ON HUMAN-COMPUTER INTERACTION.
PART IV: INTERACTING IN VARIOUS APPLICATION DOMAINS 587, 589, 591 (Julie A. Jacko ed.,
2009).
31. George Hripcsak et al., Bias Associated with Mining Electronic Health Records, 6 J.
BIOMED. DISCOVERY & COLLABORATION 48, 52 (2011); Steve Gallivan & Christina Pagel,
Modelling of Errors in Databases, 11 HEALTH CARE MGMT. SCI. 35, 39 (2008); Christina Pagel &
Steve Gallivan, Exploring Potential Consequences on Mortality Estimates of Errors in Clinical
Databases, 20 IMA J. MGMT. MATHEMATICS 385, 391 (2009). 
32. Sander Greenland, Multiple Bias Modelling for Analysis of Observational Data, 168 J.
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B. Data Can Be Incomplete or Fragmented
If EHR data are incomplete or fragmented among several different records,
data analysis will be unreliable. Researchers may often find that EHRs do not
include all of the information they need for their studies.  Clinicians collect data33
for treatment and billing purposes and thus they generally do not have research
studies in mind.  For example, a review of EHR data from the New York-34
Presbyterian Hospital clinical data warehouse revealed that when patients died of
pneumonia in the emergency room, clinicians “spent little time documenting
symptoms so that in the electronic health record, the patient appeared to be
healthy other than the death.”  Thus, researchers may find these records to be35
relatively unilluminating and a poor fit for research.
Data concerning treatment outcomes are particularly likely to be missing
because doctors and hospitals often do not follow up with patients.  For example,36
a patient who visits an emergency room for a few hours and is discharged may
choose not to seek further care or may later go to a doctor with a different EHR
system so that the hospital record provides no evidence of how the individual
ultimately fared. The absence of information could mean that the emergency
room treatment cured the patient or, by contrast, that she did not improve or even
deteriorated and sought care elsewhere.
Data fragmentation often exists because different facilities have EHR systems
that are not interoperable.  Interoperability is “the ability of different information37
technology systems and software applications to communicate, to exchange data
accurately, effectively, and consistently, and to use the information that has been
exchanged.”  Patients who are treated at multiple medical centers may have their38
records divided among different EHR systems so that their record cannot easily
be put together into an integrated whole.  EHR fragmentation is a serious39
ROYAL STAT. SOC’Y: SERIES A 267, 267-68 (2005); Craig H. Mallinckrodt et al., Assessing and
Interpreting Treatment Effects in Longitudinal Clinical Trials with Missing Data, 53 BIOL. PSYCH.
754, 755 (2003).
33. Craig Newgard et al., Electronic Versus Manual Data Processing: Evaluating the Use
of Electronic Health Records in Out-of-Hospital Clinical Research, 19 ACAD. EMERGENCY MED.
217, 224 (2012).
34. M. Alan Brookhart et al., Confounding Control in Healthcare Database Research
Challenges and Potential Approaches, 48 (Suppl 6) MED. CARE S114, S115 (2010).
35. Hripcsak et al., supra note 31, at 50.  
36. Newgard et al., supra note 33, at 225.  
37. Julia Adler-Milstein, Moving Past the EHR Interoperability Blame Game, NEJM
CATALYST (July 18, 2017), http://catalyst.nejm.org/ehr-interoperability-blame-game/ [https://
perma.cc/LGF7-D9YW].
38. Kevin Heubusch, Interoperability: What it Means, Why it Matters, 77 AHIMA 26 (Jan.
2006), http://library.ahima.org/doc?oid=60942#.WZXnGVGGM2w [https://perma.cc/9C8G-
GYF4]. 
39. Botsis et al., supra note 24, at 4 (stating that the EHR system that was mined for purposes
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obstacle for research because analysts looking at records from a particular
institution or database see only pieces of patients’ records, and key medical
information may be missing. Furthermore, researchers who examine de-identified
records from multiple facilities may mistake the records of a single patient for
records of several different individuals.  
C. Data Can Be Difficult to Extract and Lack Harmonization
As other scholars have noted, “[t]he realities of doing research across
different institutions using the EHR, even when working with sites that have an
EHR from the same vendor, are daunting.”  Different entities may use different40
versions of EHRs that collect data in different ways. Entities may customize their
EHRs to change menu items or terminology, and health care providers have
different data documentation policies and habits.  These problems and others can41
lead to a lack of semantic harmonization that adversely affects the usability of
records for research purposes. Semantic harmonization is “the process of collating
… data into a singular consistent logical view” so that data are not subject to
different interpretations.42
For example, clinicians may be able to choose among a variety of fields in
which to document a particular detail, so that researchers expecting to find it in
one field may be confused and miss it altogether. Likewise, different medical
offices use terms, phrases, and abbreviations differently. To illustrate, the
abbreviation “MS” can mean “mitral stenosis,” “multiple sclerosis,” “morphine
sulfate,” or “magnesium sulfate.”  Therefore, a reader looking at records from43
different sources might be unable to understand what “MS” means in a particular
instance.   44
Another challenge is free text narrative in EHRs. EHR systems allow users
to enter both coded information in structured fields and natural-language free text
of the study did not contain records of patients who were transferred to dedicated cancer centers
because of the severity of their disease or who had initially been treated elsewhere).
40. Kathryn H. Bowles et al., Conducting Research Using the Electronic Health Record
Across Multi-Hospital Systems: Semantic Harmonization Implications for Administrators, 43 J.
NURSING ADMIN. 355, 356 (2013).
41. Id.
42. James A. Cunningham et al., Nine Principles of Semantic Harmonization, 2016 AMIA
ANN. SYMP. PROC. ARCHIVE 451, 451 (2016).
43. Christopher G. Chute, Medical Concept Representation, in MEDICAL INFORMATICS:
KNOWLEDGE MANAGEMENT AND DATA MINING IN BIOMEDICINE 170 tbl.6-1 (Hsinchun Chen et al.
eds., 2005).
44. See The Clinical Cancer Genome Task Team of the Global Alliance for Genomics and
Health, Sharing Clinical and Genomic Data on Cancer–The Need for Global Solutions, 376 NEW.
ENG. J. MED. 2006, 2006 (2017) (stating that “[i]ncompatible data formats and a shortage of
interoperable data-harmonizing informatics tools also compromise researchers’ ability to mine
multiple data sets” as does “the absence of a single standardized cancer ontology (a machine-
readable set of defined descriptors of clinical manifestations)”).
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notes about patients.   Important information may appear in free text rather than45
in the structured fields, and information written in narrative form is much more
difficult to extract accurately from EHRs for research purposes.  As an example,46
a patient’s worsening asthma may be linked to smoking, but researchers may be
unaware of this connection if exacerbated asthma is coded, but smoking history
is described only in free-text clinical notes.  Similarly, clinicians may record47
family histories or details about adverse reactions to drugs in narrative form.48
Experts may employ natural-language processing tools to extract data from free-
text narrative, but these techniques are still developing and are often imperfect.49
Diagnoses, measurements or medical histories that are not standardized or are
inaccessible because they are not available in structured form, can significantly
hinder research efforts.  Similarly, medical vocabulary that is not harmonized50
may cause analysts to misconstrue or be unable to understand medical records.
D. Data Can Be Distorted by Software Glitches
Defects in software that is used in EHR systems or is used for data analysis
may also generate troubling errors.  This is particularly likely when scientists or51
their assistants develop complex software without consulting skilled software
developers.  Inexperienced programmers are likely to create incorrect software52
45. S. Trent Rosenbloom et al., Data from Clinical Notes: A Perspective on the Tension
between Structure and Flexible Documentation, 18 J. AM. MED. INFORMATICS ASS’N 181, 181-82
(2011).
46. The Clinical Cancer Genome Task Team of the Global Alliance for Genomics and
Health, supra note 44, at 2006 (noting the “lack of effective methods for extracting data from
electronic health records”); Hilary Townsend, Natural Language Processing and Clinical
Outcomes: The Promise and Progress of NLP for Improved Care, 84 AHIMA 44, 44-45 (Mar.
2013), http://library.ahima.org/doc?oid=106198#.Wo21_qjwa70 [https://perma.cc/B47V-RVWT].
47. Naren Ramakrishnan et al., Mining Electronic Health Records, 43 COMPUTER 95, 97
(2010).
48. Isaac S. Kohane, Using Electronic Health Records to Drive Discovery in Disease
Genomics, 12 NATURE REV. GEN. 417, 420 (2011).
49. Mike Miliard, EHR Natural Language Processing Isn't Perfect, but It’s Really Useful,
HEALTHCARE IT NEWS (May 18, 2017), http://www.healthcareitnews.com/news/ehr-natural-
language-processing-isnt-perfect-its-really-useful-tool [http://perma.cc/Z46T-VYRS].
50. Andrea L. Benin et al., How Good Are the Data? Feasible Approach to Validation of
Metrics of Quality Derived from an Outpatient Electronic Health Record, 26 AM. J. MED. QUALITY
441, 441 (2011).
51. Mi Ok Kim et al., Problems with Health Information Technology and Their Effects on
Care Delivery and Patient Outcomes: A Systematic Review, 24 J. AM. MED. INFORMATICS ASS’N,
246, 250-51 (2017).
52. Rebecca Sanders & Diane Kelly, Dealing with Risk in Scientific Software Development,
25 IEEE SOFTWARE 21, 27 (2008); Diane F. Kelly, A Software Chasm: Software Engineering and
Scientific Computing, 24 IEEE SOFTWARE 118, 118-20 (2007); Les Hatton, The Chimera of
Software Quality, 40 COMPUTER 104, 104 (2007).
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and then test it inadequately.  However, commercially developed medical53
research software is not immune to software glitches.  Ideally, scientists should54
closely collaborate with software experts to develop and thoroughly validate
software for medical research.
III. THE PROBLEM OF BIASES
Even without data blemishes and software defects, analyzing data and
drawing correct causal inferences can be extremely challenging.  This section
analyzes problems of bias affecting big data studies, in particular, selection bias,
confounding bias, measurement bias, and confirmation bias. Anyone conducting
research or interpreting its results must have a deep understanding of these
concepts.
A. Selection Bias
Selection bias relates to the way in which data subjects are selected for study
and generally occurs when selection is not randomized.  Selection bias may arise55
if individuals have the opportunity to opt out of being included in a database or
clinical study.  The subset of individuals that remain may not be representative56
of the patient population of interest because people of a particular sex, ancestry,
or socioeconomic group opted out disproportionately.  Selection bias can skew57
assessments of measures such as disease prevalence or exposure risk because the
study’s conclusions differ systematically from the true values of these measures
for the target population. That is, the researchers’ findings will not be
generalizable from the study’s particular subjects to the larger population about
which analysts wish to draw conclusions.58
53. Kelly, A Software Chasm, supra note 52, at 118. 
54. Sanders & Kelly, supra note 52, at 25; Nicole K. Henderson-MacLennan et al., Pathway
Analysis Software: Annotation Errors and Solutions, 101 MOLECULAR GENETICS & METABOLISM
134, 137-38 (2010). 
55. What researchers mean by . . . selection bias, INST. FOR WORK & HEALTH,
https://www.iwh.on.ca/wrmb/selection-bias [https://perma.cc/L355-V84M] (last visited Aug. 18,
2017).
56. KENNETH J. ROTHMAN ET AL., MODERN EPIDEMIOLOGY 136 (2008); DAVID L. FAIGMAN
ET AL., MODERN SCIENTIFIC EVIDENCE: THE LAW AND SCIENCE OF EXPERT TESTIMONY §5:16
(2011). 
57. SHARYL J. NASS ET AL., BEYOND THE HIPAA PRIVACY RULE: ENHANCING PRIVACY,
IMPROVING HEALTH THROUGH RESEARCH 209 (2009); Franklin G. Miller, Research on Medical
Records Without Informed Consent, 36 J. L. MED. & ETHICS 560, 560 (2008).
58. HERBERT I. WEISBERG, BIAS AND CAUSATION: MODELS AND JUDGMENT FOR VALID
COMPARISONS 93-94 (2010). 
236 INDIANA HEALTH LAW REVIEW [Vol. 15:227
B. Confounding Bias
Confounding bias can be a significant problem in causal effect studies.59
Causal effect studies typically seek to measure a particular treatment’s average
beneficial effect on patients or a particular exposure’s average harmful effect on
individuals. Confounding occurs when there is a common cause of the
treatment/exposure variable and the outcome variable.   60
To illustrate confounding, I offer the following hypothetical. Assume a
physician chooses among different treatment options based on the severity or
duration of a patient’s disease, and these factors also influence the outcome of
treatment.  Thus, patients at a later stage of illness receive Treatment A and those61
at an earlier stage receive Treatment B. At the same time, sicker patients, as a
general matter, will not respond as well as healthier patients to treatments because
they are frailer or their conditions are more complicated. Unless researchers
appropriately adjust for the disease stage factor, called a “confounding variable”
or “confounder,” during statistical data analysis, the confounder may produce a
false association between the treatment variable and the outcome variable, which
will distort findings regarding the causal effects of treatments. In other words,
researchers’ conclusions regarding how effective the two medications are may be
wrong because of the confounding variable: the illness severity of patients
receiving the different therapies. Treatment A may appear to be inferior to
treatment B not because it actually is less effective but because the patients
receiving treatment A are in a late stage of the disease and would not thrive no
matter what therapy was administered.  
Socioeconomic factors and patient lifestyle choices may also constitute
confounders.  Financially disadvantaged (and underinsured) individuals may
select less expensive treatments, even if those are not the best choices for them,
because those are the only affordable options. Poverty may also separately lead
to ill health, e.g. because of poor nutrition, stress, and lack of leisure time for
exercise. On the flip side, the benefits of preventive care, such as cholesterol-
lowering medication, might appear to be greater than they truly are because
health-conscious individuals who seek the intervention also take care of
themselves with exercise, low-fat diets, and other health-promoting behaviors.
Thus, these patients’ impressive outcomes are associated with a multitude of
factors rather than solely with the preventive measure.62
Analysts must strive to ascertain, accurately measure, and adjust for all
potential confounding variables in order to reduce or eliminate confounding
59. Sander Greenland, Quantifying Biases in Causal Models: Classical Confounding vs.
Collider-Stratification Bias, 14 EPIDEMIOLOGY 300, 306 (2003).
60. Miguel A. Hernan et al., A Structural Approach to Selection Bias, 15 EPIDEMIOLOGY 615,
618 (2004).
61. Bruce M. Psaty & David S. Siscovick, Minimizing Bias Due to Confounding by
Indication in Comparative Effectiveness Research, 304 J. AM. MED. ASS’N 897, 897 (2010).
62. Brookhart et al., supra note 34, at S115.
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bias.  This is no simple task in medical studies because it is often very difficult63
to discover which variables are potential confounders. Medical care often depends
on a patchwork of factors relating to the patients’ health care facilities, health
insurance, and clinicians, and to the character and circumstances of the patients
themselves, so that various influences remain hidden or obscured.  64
In clinical studies,  researchers ideally randomize treatment assignment to65
subjects in order to prevent confounding.  Thus, in my hypothetical, both66
treatment A and treatment B would be given to patients all along the disease
severity spectrum to determine their efficacy regardless of disease stage. By
contrast, in a record-based study (also called an observational study), analysts
cannot control treatment assignment, because the treatments have already been
given and recorded in patients’ medical files. Researchers must, therefore, strive
to identify and obtain the values of confounding variables and adjust for them
during data analysis.   67
C. Measurement Bias
Study results can be further compromised by measurement biases arising
from errors in measurement and data collection. Measuring devices might not be
calibrated properly or might not be sensitive enough to detect small differences
in relevant variables.  Biological samples might be stored for different lengths68
of time or in different conditions, which can cause measurement bias when they
are analyzed.  To the extent that research is based on patients’ own accounts and69
memories, outcomes might be distorted because subjects’ responses are
influenced by the questioners’ skills, patience, and apparent sympathy or by how
important and relevant patients perceive the study’s topic to be.  In addition,70
patients’ memories may be impaired, or they may lie in response to questions that
they find to be uncomfortable or embarrassing.  
For example, a study of patients’ use of opioid pain medication may have to
63. ROTHMAN ET AL. supra note 56, at 58. 
64. Brookhart et al., supra note 34, at S114.
65. In clinical studies, investigators conduct experiments using human subjects. By contrast,
observational studies involve review of existing records rather than controlled experiments. Sharona
Hoffman & Andy Podgurski, Balancing Privacy, Autonomy, and Scientific Needs in Electronic
Health Records Research, 65 SMU L. REV. 85, 98-102 (2012) (contrasting clinical trials and
observational studies) https://ssrn.com/abstract=1923187 [https://perma.cc/9X4W-766Q].
66. Jaclyn L.F. Bosco et al., A Most Stubborn Bias: No Adjustment Method Fully Resolves
Confounding by Indication in Observational Studies, 63 J. CLINICAL EPIDEMIOLOGY 64, 64 (2010)
(explaining that “confounding is best controlled by a randomized design”).
67. Id. at 64-65.
68. Gael P. Hammer et al., Avoiding Bias in Observational Studies, 106 DEUTSCHES
ÄRZTEBLATT INT’L 664, 665 (2009), https://www.aerzteblatt.de/int/archive/article?id=66288&
src=search [https://perma.cc/6RUQ-BXAN].
69. Id. at 665.
70. Id.
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rely on patients’ own reports concerning how many pills they took each day. This
is because prescription records will only reveal to researchers how many
prescriptions were filled, not how many pills were ingested and how often. Yet,
patients who are in severe pain may not record or recall the details of their
medication intake. In addition, in light of extensive publicity regarding the opioid
crisis,  individuals may tend to under-estimate or under-report the amount of71
medication they took because they do not want to be considered to be opioid
addicts.
In fact, the treatment or outcome itself can affect measurement errors.  One72
of the side effects of opioid use is cognitive impairment.  Thus, in the above73
example, patients may misremember how much medication they took in part
because the opioids themselves caused them to suffer cognitive deficits. 
D. Confirmation Bias
Confirmation bias can be defined as “an agent’s tendency to seek, interpret
and use evidence in a manner biased toward confirming her existing beliefs or
hypotheses.”  Medical researchers are under significant pressure to obtain grant74
funding and publications.  Academics thus undertake projects with particular75
results in mind, fervently hoping for dramatic findings and headline-grabbing
outcomes.  These goals, which some consider to be conflicts of interest, can lead76
analysts to make intentional or unconscious errors such as manipulating data,
distorting results, or making stronger claims than the true findings justify.77
Confirmation bias is also at play when researchers return time and again to
a database, testing and retesting data in order to find publishable results. If initial
results are not satisfactory, they look for other associations until one emerges.78
71. See, e.g., Maya Salam, The Opioid Epidemic: A Crisis Years in the Making, N.Y. TIMES,
(Oct. 26, 2017), https://www.nytimes.com/2017/10/26/us/opioid-crisis-public-health-
emergency.html?_r=0 [https://perma.cc/2388-AFQ8].
72. ROTHMAN ET AL., supra note 56, at 137-38.
73. DONALD TEATER, NAT’L SAFETY COUNCIL, THE PSYCHOLOGICAL AND PHYSICAL SIDE
EFFECTS OF PAIN MEDICATIONS 3 (2017), http://www.nsc.org/RxDrugOverdoseDocuments/
900006497-ADV-Rx-Side-Effects-WhitePaper.pdf [https://perma.cc/5Q79-ZY3Y].
74. Gary Charness & Chetan Dave, Confirmation Bias with Motivated Beliefs, 104 GAMES
AND ECON. BEHAV. 1, 1 (2017).
75. Freedman, supra note 15.
76. Id. See also Sridharan Kannan & Sivaramakrishnan Gowri, Contradicting/Negative
Results in Clinical Research: Why (Do We Get These)? Why Not (Get These Published)? Where
(to Publish)?, 5 PERSP. CLINICAL RES. 151, 151 (2014).
77. Freedman, supra note 15; Alok Jha, False Positives: Fraud and Misconduct are
Threatening Scientific Research, THE GUARDIAN (Sept. 13, 2012), https://www.theguardian.com/
science/2012/sep/13/scientific-research-fraud-bad-practice [https://perma.cc/7ZWV-Z4QB]. 
78. Freedman, supra note 15 (stating that researchers “run everything through the mill, one
at a time, and they start finding associations, and eventually conclude that vitamin X lowers the risk
of cancer Y, or this food helps with the risk of that disease.”).
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Experts caution researchers who are conducting subgroup analysis that they
should develop a small number of hypotheses a priori, before beginning their
study.  By contrast, testing a large number of subgroup hypotheses, especially79
those developed post hoc, is likely to reveal spurious subgroup differences.  For80
example, in one instance, a randomized controlled trial (“RCT”) of a treatment
for septic  patients failed to show that the therapy had a statistically significant81
benefit.  A subgroup analysis, however, seemed to demonstrate that the treatment82
was effective for individuals with a particular type of infection.  Yet, a later,83
large RCT failed to reproduce the subgroup result and proved the positive
conclusion to be false.  The root of the problem was likely that the researchers’84
initial, erroneous subgroup analysis was one of fifteen subgroup hypotheses that
they tested.  One expert explains the issue as follows: “the odds are that in any
large database … there will be a few apparent connections that are in fact merely
flukes, not real health effects—it’s a bit like combing through long, random
strings of letters and claiming there’s an important message in any words that
happen to turn up.”85
IV. OTHER DATA ANALYSIS PITFALLS
This section focuses on several additional potential research errors. These
consist of using a sample size that is too small, ignoring effect modifiers, and
disregarding causal interactions.
A. Sample Size
Researchers must ensure that their sample size is large enough to yield
credible results.  Sample size affects statistical power, that is, “the probability86
that a statistical test will indicate a significant difference when there truly is
one.”  If the sample size is too small, it is more likely that any observed87
79. Xin Sun et al., How to Use a Subgroup Analysis: Users’ Guides to the Medical
Literature, 311 JAMA 405, 408 (2014) (explaining that subgroup analysis is designed to identify
groups of patients that “respond differently to treatment than other groups.”).
80. Id. at 408.
81. Definition of Sepsis, SEPSIS ALL. (last visited August 24, 2017), http://www.sepsis.org/
sepsis/definition/ [https://perma.cc/HT9G-P2ZT] (defining sepsis as “the body’s overwhelming and
life-threatening response to infection that can lead to tissue damage, organ failure, and death.”). 
82. Xin Sun et al., supra note 79, at 408 (stating that the treatment was platelet-activating
factor receptor antagonist). 
83. Id. (stating that the subgroup was individuals with gram-negative bacterial infection).
84. Id.
85. Freedman, supra note 15.
86. David Jean Biau et al., Statistics in Brief: The Importance of Sample Size in the Planning
and Interpretation of Medical Research, 466 CLINICAL ORTHOPEDICS & RELATED RES. 2282, 2283
(2008). 
87. John Eng, Sample Size Estimation: How Many Individuals Should Be Studied?, 227
RADIOLOGY 309, 310 (2003).
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differences among subgroups (or other findings) are false and attributable purely
to chance.  For example, assume that a medication causes severe nausea and88
vomiting for one in ten patients. If researchers look at only ten medical records,
it is very possible that they will encounter only patients who tolerated the drug
well and will wrongly conclude that the drug does not cause adverse side effects
for anyone who takes it.
Determining the correct sample size for a particular study is a complicated
matter, and it behooves analysts to consult statisticians.  Sample size can be89
particularly challenging for studies targeting rare diseases or rare genetic
variations.  However, anyone relying on research outcomes for medical or health90
policy purposes should know to scrutinize sample size and question studies that
include only a small number of subjects.
B. Sampling Error
Any sample of data or subjects that researchers study may behave differently
or have different characteristics from the larger population from which the sample
is drawn because the particular collection of a study participants is just one of
many potential groups that researchers could have formed from the population of
interest.  This can lead to sampling error.  Sampling error is different from91 92
selection bias because it does not involve systematic bias, such as younger
individuals disproportionately opting out of a study; it simply occurs because of
random variability of subjects.93
Small samples are particularly vulnerable to sampling error.  For example,94
assume that investigators wish to determine whether Cleveland, Ohio has a higher
cancer rate than other locations in the United States. Assume also that they review
a sample of one hundred medical records and determine that ten percent of
88. Biau et al., supra note 86, at 2282-83; Katherine S. Button et al., Power Failure: Why
Small Sample Size Undermines the Reliability of Neuroscience, 14 NATURE REVIEWS
NEUROSCIENCE 365, 365 (2013).
89. See Eng supra note 87, at 309-12; Mohamad Amin Pourhoseingholi et al., Sample Size
Calculation in Medical Studies, 6 GASTROENTEROLOGY & HEPATOLOGY FROM BED TO BENCH 14,
16 (2013). 
90. J.H. van der Lee et al., Efficient Ways Exist to Obtain the Optimal Sample Size in Clinical
Trials in Rare Diseases, 61 J. CLINICAL EPIDEMIOLOGY 324, 324 (2008); see also Seunggeun Lee
et al., Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-
Sample Case-Control Whole-Exome Sequencing Studies, 91 AM. J. HUM. GENETICS 224, 224
(2012).
91. Id.; see MIGUEL A. HERNÁN & JAMES M. ROBINS, CAUSAL INFERENCE 119 (2017)
(ebook).
92. Douglas G. Altman & J. Martin Bland, Uncertainty and Sampling Error, 349 BMJ 1
(2014), http://www.bmj.com/content/bmj/349/bmj.g7064.full.pdf [https://perma.cc/MZ2N-9379]. 
93. See HERNÁN & ROBINS, supra note 91, at 119.
94. Stephen Tyrer & Bob Heyman, Sampling in Epidemiological Research: Issues, Hazards
and Pitfalls, 40 BJPSYCH BULLETIN 57, 57 (2016).
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patients have cancer. They thus would conclude that Cleveland has a cancer rate
that is double that of the national average which is approximately five percent.95
The problem is that this very small sample may not tell the investigators anything
about the true cancer rate in Cleveland. It may just happen by chance that an
unusually large portion of the patients whose records were reviewed had cancer.
Thus, it would be inappropriate to generalize the results of this very limited study
to the Cleveland population at large. 
C. Effect Modifiers
Research outcomes can be skewed by effect modifiers, which are
characteristics of patients or of the study that change treatment effects.  Thus,96
“the magnitude of the association between an exposure and an outcome varies
across strata of some other factor.”  To illustrate, the degree to which alcohol97
consumption affects blood pressure varies with age, gender, and smoking status,
and therefore these three attributes are effect modifiers.  Effect modification98
merits study for its own sake. Moreover, investigators examining the relationship
between alcohol and blood pressure will reach mistaken conclusions if they
ignore the effect modifiers and do not address them in their analysis.
D. Causal Interactions
Causal interactions occur when two or more factors interact to produce an
effect.  The causal factors do not have to operate at the same time, but they all99
contribute to the outcome at issue.  For example, in some cases, smoking and100
alcohol consumption interact to cause head and neck cancers.  Researchers have101
95. See Cancer Stat Facts: Cancer of Any Site, NAT’L CANCER INST., https://seer.cancer.gov/
statfacts/html/all.html [https://perma.cc/WET3-LANU] (stating that in “2014, there were an
estimated 14,738,719 people living with cancer of any site in the United States”). That same year
the U.S. population was approximately 317,000,000. Robert Schlesinger, The 2014 U.S. and World
Populations, U.S. NEWS & WORLD REP. (Dec. 31, 2013, 3:15 PM), https://www.usnews.com/
opinion/blogs/robert-schlesinger/2013/12/31/us-population-2014-317-million-and-71-billion-in-the-
world [https://perma.cc/GQY3-Z9QE].
96. Jeroen P. Jansen & Huseyin Naci, Is Network Meta-Analysis as Valid as Standard
Pairwise Meta-Analysis? It All Depends on the Distribution of Effect Modifiers, 11 BMC MED. 159,
159 (2013); See Tyler J. VanderWeele, On the Distinction between Interaction and Effect
Modification, 20 EPIDEMIOLOGY 863, 863 (2009).
97. David C. Bellinger, Effect Modification in Epidemiologic Studies of Low-Level
Neurotoxicant Exposures and Health Outcomes, 22 NEUROTOXICOLOGY & TERATOLOGY 133, 133
(2000) (footnote omitted).
98. Id.
99. Kenneth J. Rothman & Sander Greenland, Causation and Causal Inference in
Epidemiology, 95 AM. J. PUB. HEALTH S144, S145 (2005); Tyler J. VanderWeele & Mirjam J.
Knol, A Tutorial on Interaction, 3 EPIDEMIOLOGY METHODS 33, 33 (2014). 
100. Rothman & Greenland, supra note 99, at S145.
101. Id. at S146.
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found that seventy-five percent of head and neck cancer cases can be attributed
to smoking and sixty-seven percent to drinking alcohol among those who engage
in both behaviors.  While these figures may seem puzzling because they add up102
to more than one-hundred percent, they are accurate because smoking and alcohol
consumption can interact together to cause cancer. In fact, cancer is generally
caused by a multitude of factors, including diet, smoking, occupational exposures
(e.g. asbestos) genetic factors, and others.  In addition, there can be synergy103
among the different causal factors such that their interaction amplifies the effect
of the separate factors.  Although either smoking or asbestos exposure can cause104
lung cancer, the risk of lung cancer is much higher for individuals who both
smoked and breathed asbestos.  Researchers focusing on one cause of an105
outcome must be aware of potential interactions and multi-causal triggers.
V. THE PREVALENCE OF RESEARCH M ISTAKES
The pitfalls discussed thus far in the article can lead to invalid findings. How
often do researchers reach wrong conclusions? According to some experts, more
often than not. Dr. John Ioannidis, who has dedicated his career to studying the
credibility of medical research, estimates that “80 percent of non-randomized
studies (by far the most common type) turn out to be wrong, as do 25 percent of
supposedly gold-standard randomized trials, and as much as 10 percent of the
platinum-standard large randomized trials.”  This section probes the prevalence106
of research mistakes.
A. Association v. Causation
If researchers succumb to some of the pitfalls described in the Article, they
may mistake mere association for actual causation.  They may identify107
associations between certain exposures and particular outcomes but wrongly
conclude that there is an actual causal relationship between them.  To illustrate,108
102. Id.; See also ROTHMAN ET AL., supra note 56, at 71.
103. Rothman & Greenland, supra note 99, at S146; VanderWeele & Knol, supra note 99, at
33.
104. VanderWeele & Knol, supra note 99, at 35.
105. Id.
106. Freedman, supra note 15; see also John P. A. Ioannidis, Why Most Published Research
Findings Are False, 2 PLOS MED. 0696 (2005), http://journals.plos.org/plosmedicine/article?id=
10.1371/journal.pmed.0020124 [https://perma.cc/4GDL-E6FP]. 
107. See, e.g., Austin Bradford Hill, The Environment and Disease: Association or
Causation?, 58 PROC. ROYAL SOC’Y MED. 295, 295–300 (1965); Arvid Sjölander, The Language
of Potential Outcomes, in CAUSALITY: STATISTICAL PERSPECTIVES AND APPLICATIONS 6, 9 (Carlo
Berzuini et al. eds., 2012).
108. See Stephen Choi et al., The Power of Proxy Advisors: Myth or Reality? 59 EMORY L.J.
869, 879–85 (2010) (discussing the difference between correlation and causation); Csaba P.
Kovesdy & Kamyar Kalantar-Zadeh, Observational Studies vs. Randomized Controlled Trials: 
Avenues to Causal Inference in Nephrology, 19 ADVANCED CHRONIC KIDNEY DISEASE 11, 11-12
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data analysis may suggest that drinking coffee increases an individual’s risk of
lung cancer.  The association would likely disappear, however, when analysts109
adjust for the fact that, generally, coffee drinkers are more likely to smoke
cigarettes than non-coffee consumers,  and it is cigarette smoking that, in truth,110
increases lung cancer risk.  Researchers who confuse the association between111
coffee and lung cancer for a causal relationship would stumble because of
confounding bias.  Scientists have found that a genetic variant influences both112
caffeine consumption and smoking, which in turn increases the risk of lung
cancer, and thus the genetic factor is a confounder.  Moreover, smoking itself113
may cause individuals to drink more coffee because nicotine increases the
metabolism of caffeine, so that smokers lose the stimulating effects of caffeine
more quickly.  Smoking is thus a confounder that causes both increased coffee114
drinking and lung cancer. Without awareness of the genetic and smoking
confounders, researchers could reach erroneous conclusions about the cause of
lung cancer.
As a second example, selection bias can cause analysts to mistake association
for causation. Suppose researchers are interested in the question of whether folic
acid, taken during pregnancy, can prevent fetal heart defects. Assume too that the
investigators include only babies that are born live and exclude from the study
fetuses that are miscarried. Researchers might conclude that folic acid is linked
to a reduction in the number of fetal heart defects. However, no causal link can
be assumed because fetuses that were miscarried were not studied.  Some of115
these fetuses, in fact, may not have survived because of heart defects. Researchers
who posit that folic acid reduces fetal heart defects based on these results would
have failed to establish an actual causal relationship between the treatment and
outcome.
B. Inability to Replicate Study Findings
Research errors can make it impossible for researchers to replicate studies and
confirm results. Although it may be far more exciting to make new discoveries,116
(2012).
109. Bellinger, supra note 97, at 133.
110. Jorien L. Treur et al., Associations between Smoking and Caffeine Consumption in Two
European Cohorts, 111 ADDICTION 1059, 1059 (2016) (stating that “[t]here appears to be a positive
association between smoking and caffeine consumption in the Netherlands and the United
Kingdom”).
111. Id.
112. See supra Part III.B.
113. Treur et al. supra note 110, at 1066; Akshat Rathi, There’s a Reason Why Smokers Drink
More Coffee, QUARTZ (Mar. 7, 2017), https://qz.com/926328/scientists-can-explain-why-smokers-
drink-more-coffee-genetics-metabolism-and-blunted-taste-buds/ [https://perma.cc/9DKM-8CFU].
114. Treur et al. supra note 110, at 1066; Rathi, supra note 113.
115. HERNÁN & ROBINS, supra note 91, at 95. 
116. Michael Price, To Replicate or Not To Replicate?, SCI. (Dec. 2, 2011, 10:00 AM),
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the work of reproducing prior study results is essential to scientific integrity and
the validity of research claims.  117
Replicability is a very significant problem for both clinical and observational
research. To replicate a clinical trial, a new group of investigators conducts the
experiment again, and in the case of a record-based study, new analysts examine
a different data set and try to obtain the same findings.  But if the initial study118
outcome is erroneous because of data quality, biases, and/or the other
shortcomings discussed above, it will not be reproducible. On the other hand, if
replication studies are themselves tainted by any of these problems, they will fail
even if the original results are legitimate.  
In 2005, Dr. John Ioannidis published a study in JAMA, a top medical journal,
focusing on forty-nine of the most highly regarded research findings published
during the prior thirteen years.  Of these, forty-five studies claimed to have119
discovered effective interventions, and thirty-four of these findings were retested
in order to validate results. Astonishingly, upon retesting, fourteen of the claims
(forty-one percent) were shown to be incorrect or exaggerated.120
In a highly publicized 2015 article, the journal Science featured “a large-
scale, collaborative effort to obtain an initial estimate of the reproducibility of
psychological science.”  Investigators attempted to reproduce the outcomes of121
one-hundred recent peer-reviewed psychology experiments, but were successful
in only thirty-nine cases.  122
Commentators bemoan the “replication crisis,” and journalists have written
articles with headlines such as “Is Science Broken?”  Others are less pessimistic123
http://www.sciencemag.org/careers/2011/12/replicate-or-not-replicate [https://perma.cc/L5WT-
PSGL]; Timothy M. Errington et al., An Open Investigation of the Reproducibility of Cancer
Biology Research, ELIFE ,  (Dec. 10, 2014), https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC4270077/ [https://perma.cc/Y2DS-JVDW] (asserting that “careers are made by
producing exciting new results at the frontiers of knowledge, not by verifying prior discoveries”). 
117. Open Science Collaboration, Estimating the Reproducibility of Psychological Science,
349 SCI. 943, 943 (2015); Matthew C. Makel & Jonathan A. Plucker, Facts Are More Important
Than Novelty: Replication in the Education Sciences, 43 EDUC. RESEARCHER 304, 304 (2014); Jens
B. Asendorpf et al., Recommendations for Increasing Replicability in Psychology, 27 EUR. J.
PERSONALITY 108, 108 (2013) (“Replicability of findings is at the heart of any empirical science.”).
118. Makel & Plucker, supra note 113, at 304 (emphasizing “the importance of third-party,
direct replications in helping education research improve its ability to shape education policy and
practice); Arturo Casadevall & Ferric C. Fang, Reproducible Science, 78 INFECTION & IMMUNITY
4972, 4972-75 (2010). 
119. John P. A. Ioannidis, Contradicted and Initially Stronger Effects in Highly Cited Clinical
Research, 294 JAMA 218, 218 (2005) (“The size of the sample studied is a major determinant of
the risk of reporting false-negative findings”).
120. Id.
121. Open Science Collaboration, supra note 117, at 943. 
122. Id.
123. Daniel Engber, Is Science Broken Or Is It Self Correcting?, SLATE (Aug. 21, 2017, 6:00
AM ) ,  h t t p : / / www.s l a t e . co m/ar t i c les /h ea l th _ an d _ sc i ence / sc i en ce /20 1 7 / 0 8 /
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about replication failures and state that “[w]e should just be looking at an
accumulating evidence paradigm, where we’re getting closer and closer to
truth.”  Still others argue that replications might fail because they themselves124
are flawed, that is, the later studies are not conducted under the same conditions
by people with the same level of expertise as the original investigators.   125
Nevertheless, repeated replication failures have distressed the scientific
community and all who care about the medical research endeavor. Many agree
that “[r]eplication is central to the progress of science: if others cannot reproduce
the evidence backing a scientific claim, then the claim loses status as scientific
knowledge.”  The Internet can enable exchange of data protocols, and software,126
and such data sharing should greatly facilitate replication efforts. Researchers
should take advantage of these opportunities and also do their utmost to ensure
that their studies are free of errors and biases so that they can be duplicated by
skilled analysts.
VI. CONCLUSION
This Article has analyzed numerous challenges that researchers face in
analyzing big data (and other health information). These include data quality
deficiencies; selection, confounding, measurement, and confirmation biases;
inadequate sample sizes; sampling errors; effect modifiers; and causal
interactions. All of these can cause researchers to mistake mere associations for
causal relationships and to reach conclusions that are invalid and cannot be
replicated in subsequent studies. Erroneous research findings can mislead
legislators, regulators, and lawyers, who use them for purposes of policy-making
or litigation. 
Formulating solutions for these research obstacles is beyond the scope of this
paper, and I have done so in prior work.  Suffice it to say that well-developed127
science_is_not_self_correcting_science_is_broken.html [https://perma.cc/5HY7-JYNN]; Joel
Achenbach, Many Scientific Studies Can’t Be Replicated. That’s a Problem, WASH. POST (Aug.
27, 2015), https://www. washingtonpost.com/news/speaking-of-science/wp/2015/08/27/trouble-in-
science-massive-effort-to-reproduce-100-experimental-results-succeeds-only-36-
times/?utm_term=.ab0793214a51 [https://perma.cc/GTT9-6PPL].
124. Christie Aschwanden, Failure Is Moving Science Forward: The replication crisis is a
sign that science is working, FIVETHIRTYEIGHT (Mar. 24, 2016), https://fivethirtyeight.com/
features/failure-is-moving-science-forward/ [https://perma.cc/ZXS6-9PYT].
125. Mina Bissell, Reproducibility: The Risks of the Replication Drive, NATURE (Nov. 20,
2013), http://www.nature.com/news/reproducibility-the-risks-of-the-replication-drive-1.14184
[https://perma.cc/W5JZ-FHY6] (arguing that “[p]eople trying to repeat others' research often do
not have the time, funding or resources to gain the same expertise with the experimental protocol
as the original authors, who were perhaps operating under a multi-year federal grant and aiming
for a high-profile publication.”); Errington et al., supra note 116 (discussing whether failure to
replicate always means “that the original result was a false positive”). 
126. Errington et al., supra note 116.
127. See Hoffman & Podgurski, supra note 1, at 527-38; SHARONA HOFFMAN, Medical Big
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techniques can allow researchers to adjust for biases and identify true causal
factors.  However, the pitfalls of big data analysis are numerous, and anyone128
conducting, reviewing, or relying upon it must be aware of their existence. We
all must know what questions to ask and what potential flaws to scrutinize,
whether we be scientists, attorneys, policy-makers, or members of the interested
public.129
Data Quality and Analysis Concerns, in ELECTRONIC HEALTH RECORDS AND MEDICAL BIG DATA:
LAW AND POLICY 160-67 (Cambridge U. Press 2016).
128. Hammer et al., supra note 68, at 667; Kovesdy & Kalantar-Zadeh, supra note 108, at 15. 
129. David Faraoni & Simon Thomas Schaefer, Randomized Controlled Trials vs.
Observational Studies: Why Not Just Live Together?, BMC ANESTHESIOLOGY (Oct. 21, 2016),
ht tps: / /bmcanesthesiol .biomedcentral .com/articles/10.1186/s12871-016-0265-3
[https://perma.cc/5TM5-9CFJ] (urging that “it remains our accountability to scrutinize methods,
controls and conclusions drawn in all the papers we read”).
